These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1448595)

  • 21. [Thyrocalcitonin and amyloid in medullary carcinoma of the thyroid].
    Fujimoto Y; Oka A; Suzuki H; Ogata E; Eto S
    Saishin Igaku; 1970 Feb; 5(2):460-9. PubMed ID: 5438492
    [No Abstract]   [Full Text] [Related]  

  • 22. Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT.
    Zatelli MC; Tagliati F; Taylor JE; Piccin D; Culler MD; degli Uberti EC
    Horm Metab Res; 2002 May; 34(5):229-33. PubMed ID: 12063634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An efficient method to detect calcitonin mRNA in normal and neoplastic rat C-cells (medullary thyroid carcinoma) by in situ hybridization using a digoxigenin-labeled synthetic oligodeoxyribonucleotide probe.
    Le Guellec P; Dumas S; Volle GE; Pidoux E; Moukhtar MS; Treilhou-Lahille F
    J Histochem Cytochem; 1993 Mar; 41(3):389-95. PubMed ID: 8429201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No effect of cimetidine on calcitonin secretion from medullary thyroid carcinoma.
    Emmertsen K; Nielsen HE; Mosekilde L; Hansen HH
    Acta Med Scand; 1980; 207(5):367-9. PubMed ID: 7386230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin inhibits the pentagastrin-induced release of serum calcitonin in medullary carcinoma of the thyroid.
    Gordin A; Lamberg BA; Pelkonen R; Almqvist S
    Clin Endocrinol (Oxf); 1978 Apr; 8(4):289-93. PubMed ID: 647984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoassay of calcitonin in rat medullary thyroid carcinoma.
    Deftos LJ; Boorman GA; Roos BA
    Horm Metab Res; 1976 Jan; 8(1):83-4. PubMed ID: 1248795
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcitonin gene-related peptide and calcitonin secretion from a human medullary thyroid carcinoma cell line: effects of ionomycin, phorbol ester and forskolin.
    Haller-Brem S; Muff R; Fischer JA
    J Endocrinol; 1988 Oct; 119(1):147-52. PubMed ID: 2848088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of calcitonin gene-related peptide from a human medullary carcinoma of the thyroid in vitro.
    Ohashi M; Fujio N; Ibayashi H
    Experientia; 1986 Jul; 42(7):829-30. PubMed ID: 3488230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunofluorescent localisation of calcitonin in medullary C-cell thyroid carcinoma, using antibody to the pure porcine hormone.
    Bussolati G; Foster GV; Clark MB; Pearse AG
    Virchows Arch B Cell Pathol; 1969; 2(3):234-8. PubMed ID: 4978695
    [No Abstract]   [Full Text] [Related]  

  • 30. Ultrastructural study of thyroid medullary carcinoma.
    Kakudo K; Miyauchi A; Katayama S
    Acta Pathol Jpn; 1977 Sep; 27(5):605-22. PubMed ID: 201148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies in familial thyroid cancer.
    Melvin KE; Tashjian AH; Miller HA
    Trans Assoc Am Physicians; 1971; 84():144-51. PubMed ID: 5164299
    [No Abstract]   [Full Text] [Related]  

  • 32. Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells.
    Nakagawa T; Mabry M; de Bustros A; Ihle JN; Nelkin BD; Baylin SB
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5923-7. PubMed ID: 3112776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum and urine calcitonin levels in patients with medullary thyroid carcinoma and with non-thyroidal cancer, and their immunological size-heterogeneity (author's transl)].
    Morimoto S; Onishi T; Imanaka S; Kumahara Y; Okada Y; Takai S; Miyauchi A; Nishioka Y
    Nihon Naibunpi Gakkai Zasshi; 1981 Aug; 57(8):1127-38. PubMed ID: 6274709
    [No Abstract]   [Full Text] [Related]  

  • 34. VII. Hormonal control of calcium homoeostasis.
    Catt KJ
    Lancet; 1970 Aug; 2(7666):255-7. PubMed ID: 4193704
    [No Abstract]   [Full Text] [Related]  

  • 35. [The importance of titrating immunoreactive calcitonin in medullary carcinoma of the thyroid gland].
    Neradilová M; Nĕmec J; Soutorová M; Bednár J
    Rozhl Chir; 1987 Feb; 66(2):114-8. PubMed ID: 3563716
    [No Abstract]   [Full Text] [Related]  

  • 36. Disseminated calcitonin-poor medullary thyroid carcinoma in a patient with calcitonin-rich primary tumor.
    Ruppert JM; Eggleston JC; deBustros A; Baylin SB
    Am J Surg Pathol; 1986 Jul; 10(7):513-8. PubMed ID: 2873751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in calcium metabolism: application to medullary carcinoma of the thyroid and hyperparathyroidism.
    Kaplan EL
    Surg Annu; 1973; 5():97-119. PubMed ID: 4602211
    [No Abstract]   [Full Text] [Related]  

  • 38. Medullary carcinoma and thyrocalcitonin.
    Tubiana M; Milhaud G; Coutris G; Lacour J; Parmentier C; Bok B
    Br Med J; 1968 Oct; 4(5623):87-9. PubMed ID: 5748583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dietary calcium on secretion of calcitonin and gastrin in rats with medullary thyroid carcinoma.
    Hongslo CF; Myhre L; Flaten O; Johannessen JW; Gautvik KM; Ekeland A
    Acta Endocrinol (Copenh); 1981 Jul; 97(3):376-83. PubMed ID: 7257702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACTH and calcitonin secreting medullary carcinoma of the thyroid.
    Croughs RJ; Eastham WN; Hackeng WH; Schopman W; Feltkamp-Vroom TM; Dolman A; Hennemann G
    Clin Endocrinol (Oxf); 1972 Apr; 1(2):157-71. PubMed ID: 4352168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.